{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:08:18Z","timestamp":1789949298232,"version":"4.0.1"},"reference-count":53,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.3892\/or.2012.1928","type":"journal-article","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T06:13:36Z","timestamp":1343024016000},"page":"1443-1452","source":"Crossref","is-referenced-by-count":25,"title":["Serum interleukin-15 levels in cancer patients with cachexia"],"prefix":"10.3892","volume":"28","author":[{"given":"PEDRO L.","family":"MART\u00cdNEZ-HERN\u00c1NDEZ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1NGEL","family":"HERNANZ-MAC\u00cdAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CARMEN","family":"G\u00d3MEZ-CANDELA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CRISTINA","family":"GRANDE-ARAG\u00d3N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAIME","family":"FELIU-BATLLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAVIER","family":"CASTRO-CARPE\u00d1O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ISABEL","family":"MART\u00cdNEZ-MU\u00d1OZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LAURA","family":"ZURITA-ROSA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARTA","family":"VILLARINO-SANZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CONCEPCI\u00d3N","family":"PRADOS-S\u00c1NCHEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOAQU\u00cdN S\u00c1NCHEZ","family":"GARC\u00cdA-GIR\u00d3N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,7,23]]},"reference":[{"key":"key20180107215518_b1-or-28-04-1443","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"key20180107215518_b2-or-28-04-1443","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"key20180107215518_b3-or-28-04-1443","first-page":"159","article-title":"Pathogenesis of cancer cachexia","volume":"1","author":"Tisdale","year":"2003","journal-title":"J Support Oncol"},{"key":"key20180107215518_b4-or-28-04-1443","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/83.4.735","article-title":"Cachexia: pathophysiology and clinical relevance","volume":"83","author":"Morley","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"key20180107215518_b5-or-28-04-1443","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"key20180107215518_b6-or-28-04-1443","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","article-title":"Cachexia as a major underestimated and unmet medical need: facts and nunber","volume":"1","author":"Haehling","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"key20180107215518_b7-or-28-04-1443","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.8178155","article-title":"Cloning of a T cell growth factor that interacts with the \u03b2 chain of the interleukin-2 receptor","volume":"264","author":"Grabstein","year":"1994","journal-title":"Science"},{"key":"key20180107215518_b8-or-28-04-1443","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1073\/pnas.91.11.4935","article-title":"A lymphokine, provisionally designed interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells","volume":"91","author":"Burton","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107215518_b9-or-28-04-1443","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/j.1460-2075.1994.tb06576.x","article-title":"Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15","volume":"13","author":"Giri","year":"1994","journal-title":"EMBO J"},{"key":"key20180107215518_b10-or-28-04-1443","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1210\/endo.136.8.7628408","article-title":"Interleukin-15: a novel anabolic cytokine for skeletal muscle","volume":"136","author":"Quinn","year":"1995","journal-title":"Endocrinology"},{"key":"key20180107215518_b11-or-28-04-1443","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/excr.2002.5624","article-title":"Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders","volume":"280","author":"Quinn","year":"2002","journal-title":"Exp Cell Res"},{"key":"key20180107215518_b12-or-28-04-1443","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","article-title":"Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats","volume":"83","author":"Carb\u00f3","year":"2000","journal-title":"Br J Cancer"},{"key":"key20180107215518_b13-or-28-04-1443","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/bbrc.2000.2462","article-title":"DNA fragmentation occurs in skeletal muscle during tumor growth: a link with cancer cachexia?","volume":"270","author":"Van Royen","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107215518_b14-or-28-04-1443","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.febslet.2004.05.066","article-title":"Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats","volume":"569","author":"Figueras","year":"2004","journal-title":"FEBS Lett"},{"key":"key20180107215518_b15-or-28-04-1443","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.febslet.2004.12.050","article-title":"Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia","volume":"579","author":"Busquets","year":"2005","journal-title":"FEBS Lett"},{"key":"key20180107215518_b16-or-28-04-1443","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and trietylene thiophosphoramide","volume":"11","author":"Zubrod","year":"1960","journal-title":"J Chron Dis"},{"key":"key20180107215518_b17-or-28-04-1443","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ajcn\/69.4.603","article-title":"Use of the leg-to-leg bioelectrical impedance method in assessing body-composition change in obese women","volume":"69","author":"Utter","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"key20180107215518_b18-or-28-04-1443","first-page":"79","article-title":"Evaluaci\u00f3n de la Astenia","volume-title":"Valoraci\u00f3n cl\u00ednica del paciente con c\u00e1ncer","author":"Ord\u00f3nez","year":"2006"},{"key":"key20180107215518_b19-or-28-04-1443","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180107215518_b20-or-28-04-1443","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107215518_b21-or-28-04-1443","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: and international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20180107215518_b22-or-28-04-1443","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/gerona\/59.8.M855","article-title":"Effects of megestrol acetate on circulating interleukin-15 and interleukin-18 concentrations in healthy elderly men","volume":"59","author":"Lambert","year":"2004","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key20180107215518_b23-or-28-04-1443","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1152\/japplphysiol.00491.2004","article-title":"Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses","volume":"97","author":"Riechman","year":"2004","journal-title":"J Appl Physiol"},{"key":"key20180107215518_b24-or-28-04-1443","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1155\/MI.2005.60","article-title":"Modification of interleukin-15 serum levels in workers exposed to chemotherapeutic agents","volume":"1","author":"Spatari","year":"2005","journal-title":"Mediators Inflamm"},{"key":"key20180107215518_b25-or-28-04-1443","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/MI.2005.245","article-title":"Age-related modifications in circulating IL-15 levels in humans","volume":"4","author":"Gangemi","year":"2005","journal-title":"Mediators Inflamm"},{"key":"key20180107215518_b26-or-28-04-1443","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00262-005-0005-x","article-title":"Interferon-\u03b1\/\u03b2 upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-\u03b1\/\u03b2 treatment","volume":"55","author":"Yamaji","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107215518_b27-or-28-04-1443","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1113\/jphysiol.2007.139618","article-title":"Expression of interleukin-15 in human skeletal muscle-effect of excercise and muscle fibre type composition","volume":"584","author":"Nielsen","year":"2007","journal-title":"J Physiol"},{"key":"key20180107215518_b28-or-28-04-1443","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1210\/jc.2007-2561","article-title":"Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass","volume":"93","author":"Nielsen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107215518_b29-or-28-04-1443","first-page":"186","article-title":"Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker","volume":"21","author":"Lamana","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"key20180107215518_b30-or-28-04-1443","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/172460089801300309","article-title":"Blood concentrations of interleukin-15 in cancer patients and their variations during interleukin-2 immunotherapy: preliminary considerations","volume":"13","author":"Lissoni","year":"1998","journal-title":"Int J Biol Markers"},{"key":"key20180107215518_b31-or-28-04-1443","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cyto.2007.02.022","article-title":"Serum levels of interleukin-15 and interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma","volume":"37","author":"Pappa","year":"2007","journal-title":"Cytokine"},{"key":"key20180107215518_b32-or-28-04-1443","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.1997.4861382.x","article-title":"Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-\u03b1) receptors in type C chronic liver disease","volume":"109","author":"Kakumu","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"key20180107215518_b33-or-28-04-1443","first-page":"455","article-title":"Serum interleukin-15 levels are not elevated in patients with stage I and II mycosis fungoides","volume":"80","author":"Sugaya","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"key20180107215518_b34-or-28-04-1443","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1158\/0008-5472.CAN-07-6842","article-title":"The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer","volume":"68","author":"Badoual","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107215518_b35-or-28-04-1443","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/914945","article-title":"Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphomas","author":"Porrata","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"key20180107215518_b36-or-28-04-1443","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cncr.24729","article-title":"Expression of interleukin-15 in primary adult acute lymphoblastic leukemia","volume":"116","author":"Wu","year":"2010","journal-title":"Cancer"},{"key":"key20180107215518_b37-or-28-04-1443","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diabres.2005.02.007","article-title":"IL-15 is elevated in serum patients with type 1 diabetes mellitus","volume":"69","author":"Kuczynski","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"key20180107215518_b38-or-28-04-1443","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1080\/02640410903352923","article-title":"Effects of resistance training on resistin, leptin, cytokines, and muscle force in elderly post-menopausal women","volume":"27","author":"Prestes","year":"2009","journal-title":"J Sports Sci"},{"key":"key20180107215518_b39-or-28-04-1443","first-page":"185","article-title":"Serum levels of cancer antigen 125 and interleukin-15 in relation to the nutrition status of peritoneal dialysis patients","volume":"20","author":"Grzegorzewska","year":"2004","journal-title":"Adv Perit Dial"},{"key":"key20180107215518_b40-or-28-04-1443","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-4165(00)00188-4","article-title":"Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control","volume":"1526","author":"Carb\u00f3","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"key20180107215518_b41-or-28-04-1443","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-4165(02)00148-4","article-title":"Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue","volume":"1570","author":"Alvarez","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"key20180107215518_b42-or-28-04-1443","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cellbi.2005.02.005","article-title":"Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signalling pathway","volume":"29","author":"Quinn","year":"2005","journal-title":"Cell Biol Int"},{"key":"key20180107215518_b43-or-28-04-1443","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/14653249.2010.515582","article-title":"A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer","volume":"13","author":"Geller","year":"2011","journal-title":"Cytotherapy"},{"key":"key20180107215518_b44-or-28-04-1443","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","article-title":"Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens","volume":"26","author":"Dudley","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107215518_b45-or-28-04-1443","first-page":"471","article-title":"Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect","volume":"16","author":"Busquets","year":"2005","journal-title":"Int J Mol Med"},{"key":"key20180107215518_b46-or-28-04-1443","doi-asserted-by":"crossref","first-page":"S2052","DOI":"10.1093\/jn\/133.6.2052S","article-title":"Amino acids as regulators of proteolysis","volume":"133","author":"Kadowaki","year":"2003","journal-title":"J Nutr"},{"key":"key20180107215518_b47-or-28-04-1443","doi-asserted-by":"crossref","first-page":"S1553","DOI":"10.1093\/jn\/135.6.1553S","article-title":"The role of leucine in the regulation of protein metabolism","volume":"135","author":"Garlick","year":"2005","journal-title":"J Nutr"},{"key":"key20180107215518_b48-or-28-04-1443","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJM199612193352507","article-title":"Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway","volume":"335","author":"Mitch","year":"1996","journal-title":"N Engl J Med"},{"key":"key20180107215518_b49-or-28-04-1443","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.clnu.2007.08.003","article-title":"Good agreement between bioelectrical impedance and dual-energy X-ray absorptiometry for estimating changes in body composition during weight loss in overweight young women","volume":"26","author":"Thomson","year":"2007","journal-title":"Clin Nutr"},{"key":"key20180107215518_b50-or-28-04-1443","doi-asserted-by":"crossref","first-page":"S1123","DOI":"10.3945\/ajcn.2010.28608A","article-title":"Skeletal muscle loss: cachexia, sarcopenia, and inactivity","volume":"91","author":"Evans","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"key20180107215518_b51-or-28-04-1443","first-page":"271","article-title":"Variation in body composition associated with sex and ethnicity","volume-title":"Human Body Composition","author":"Malina","year":"2007","edition":"2nd edition"},{"key":"key20180107215518_b52-or-28-04-1443","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1176\/jnp.2007.19.3.318","article-title":"Circulating interleukin-15 in dementia disorders","volume":"19","author":"Rentzos","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key20180107215518_b53-or-28-04-1443","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.drudis.2008.10.010","article-title":"Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity","volume":"14","author":"Argil\u00e9s","year":"2009","journal-title":"Drug Discov Today"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.1928\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T10:50:22Z","timestamp":1561978222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.1928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,23]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,7,23]]},"published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.3892\/or.2012.1928"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.1928","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,23]]}}}